Return On Equity of ZEVRA THERAPEUTICS, INC. from 30 Sep 2015 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ZEVRA THERAPEUTICS, INC. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 31 Dec 2025.
  • ZEVRA THERAPEUTICS, INC. Return On Equity for the quarter ending 31 Dec 2025 was 75%.
  • ZEVRA THERAPEUTICS, INC. annual Return On Equity for 2025 was 75%.
  • ZEVRA THERAPEUTICS, INC. annual Return On Equity for 2024 was -221%, a 190% decline from 2023.
  • ZEVRA THERAPEUTICS, INC. annual Return On Equity for 2023 was -76%, a 177% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

ZEVRA THERAPEUTICS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 75% +296% 01 Oct 2025 31 Dec 2025
Q3 2025 43% +211% 01 Jul 2025 30 Sep 2025
Q2 2025 4% +135% 01 Apr 2025 30 Jun 2025
Q1 2025 -201% -116% -135% 01 Jan 2025 31 Mar 2025
Q4 2024 -221% -145% -190% 01 Oct 2024 31 Dec 2024
Q3 2024 -168% -136% -426% 01 Jul 2024 30 Sep 2024
Q2 2024 -131% -107% -463% 01 Apr 2024 30 Jun 2024
Q1 2024 -86% -39% -84% 01 Jan 2024 31 Mar 2024
Q4 2023 -76% -49% -177% 01 Oct 2023 31 Dec 2023
Q3 2023 -32% +1.8% +5.4% 01 Jul 2023 30 Sep 2023
Q2 2023 -23% +3.5% +13% 01 Apr 2023 30 Jun 2023
Q1 2023 -47% -46% -45867% 01 Jan 2023 31 Mar 2023
Q4 2022 -27% -20% -260% 01 Oct 2022 31 Dec 2022
Q3 2022 -34% -19% -122% 01 Jul 2022 30 Sep 2022
Q2 2022 -27% +29% +52% 01 Apr 2022 30 Jun 2022
Q1 2022 -0.1% -65% -100% 01 Jan 2022 31 Mar 2022
Q4 2021 -7.6% -27% -139% 01 Oct 2021 31 Dec 2021
Q3 2021 -15% -36% -174% 01 Jul 2021 30 Sep 2021
Q2 2021 -56% -67% -588% 01 Apr 2021 30 Jun 2021
Q1 2021 64% +40% +165% 01 Jan 2021 31 Mar 2021
Q4 2020 20% -13% -40% 01 Oct 2020 31 Dec 2020
Q3 2020 21% -11% -36% 01 Jul 2020 30 Sep 2020
Q2 2020 11% -41% -78% 01 Apr 2020 30 Jun 2020
Q1 2020 24% -29% -54% 01 Jan 2020 31 Mar 2020
Q4 2019 33% -37% -53% 01 Oct 2019 31 Dec 2019
Q3 2019 32% -46% -59% 01 Jul 2019 30 Sep 2019
Q2 2019 53% -32% -38% 01 Apr 2019 30 Jun 2019
Q1 2019 53% -42% -44% 01 Jan 2019 31 Mar 2019
Q4 2018 69% -28% -28% 01 Oct 2018 31 Dec 2018
Q3 2018 78% -44% -36% 01 Jul 2018 30 Sep 2018
Q2 2018 84% -97% -54% 01 Apr 2018 30 Jun 2018
Q1 2018 95% -98% -51% 01 Jan 2018 31 Mar 2018
Q4 2017 97% -70% -42% 01 Oct 2017 31 Dec 2017
Q3 2017 122% -81% -40% 01 Jul 2017 30 Sep 2017
Q2 2017 182% +2.3% +1.3% 01 Apr 2017 30 Jun 2017
Q1 2017 193% -672% -78% 01 Jan 2017 31 Mar 2017
Q4 2016 167% -161% -49% 01 Oct 2016 31 Dec 2016
Q3 2016 203% -15% -6.8% 01 Jul 2016 30 Sep 2016
Q2 2016 179% 01 Apr 2016 30 Jun 2016
Q1 2016 865% 01 Jan 2016 31 Mar 2016
Q4 2015 328% 01 Oct 2015 31 Dec 2015
Q3 2015 218% 01 Jul 2015 30 Sep 2015

ZEVRA THERAPEUTICS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 75% +296% 01 Jan 2025 31 Dec 2025
2024 -221% -145% -190% 01 Jan 2024 31 Dec 2024
2023 -76% -49% -177% 01 Jan 2023 31 Dec 2023
2022 -27% -20% -260% 01 Jan 2022 31 Dec 2022
2021 -7.6% -27% -139% 01 Jan 2021 31 Dec 2021
2020 20% -13% -40% 01 Jan 2020 31 Dec 2020
2019 33% -37% -53% 01 Jan 2019 31 Dec 2019
2018 69% -28% -28% 01 Jan 2018 31 Dec 2018
2017 97% -70% -42% 01 Jan 2017 31 Dec 2017
2016 167% -161% -49% 01 Jan 2016 31 Dec 2016
2015 328% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.